Trial NCT01247922

View at ClinicalTrials.gov 
Org. Study IDs: OSI-774-206
Secondary IDs: 2010-023478-38

Last trial update was posted on 2019-06-19

MeSH Interventions

Erlotinib Hydrochloride

MeSH Conditions

Ependymoma

Other Conditions


Stopping Reasons

In a pre-planned interim analysis, OSI-774-205 met futility for efficacy with no safety concerns. As a result, the companion trial, OSI-774-206 has been stopped

Limitations And Caveats

Company makes no warranties or representations of any kind as to the posting, expressed or implied, including warranties of merchantability and fitness for a particular purpose, and shall not be liable for any damages.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID